Centogene N.V.
CNTGF
$0.10
$0.001.70%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.87M | 13.01M | 13.40M | 13.20M | 13.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.87M | 13.01M | 13.40M | 13.20M | 13.33M |
| Cost of Revenue | 8.14M | 8.22M | 8.56M | 8.43M | 7.42M |
| Gross Profit | 4.74M | 4.79M | 4.84M | 4.77M | 5.91M |
| SG&A Expenses | 11.63M | 11.75M | 13.26M | 13.07M | 10.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.71M | -1.73M | -581.80K | -573.20K | -1.45M |
| Total Operating Expenses | 21.02M | 21.25M | 24.97M | 24.60M | 20.75M |
| Operating Income | -8.15M | -8.24M | -11.57M | -11.40M | -7.43M |
| Income Before Tax | -5.81M | -5.88M | -13.30M | -13.11M | -8.02M |
| Income Tax Expenses | 147.50K | 149.10K | 7.10K | 7.00K | -36.80K |
| Earnings from Continuing Operations | -5.96M | -6.03M | -13.31M | -13.11M | -7.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 368.90K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.96M | -6.03M | -13.31M | -13.11M | -7.62M |
| EBIT | -8.15M | -8.24M | -11.57M | -11.40M | -7.43M |
| EBITDA | -7.21M | -6.91M | -9.50M | -9.36M | -6.19M |
| EPS Basic | -0.21 | -0.21 | -0.48 | -0.47 | -0.28 |
| Normalized Basic EPS | -0.21 | -0.21 | -0.30 | -0.29 | -0.18 |
| EPS Diluted | -0.21 | -0.22 | -0.48 | -0.47 | -0.28 |
| Normalized Diluted EPS | -0.21 | -0.21 | -0.30 | -0.29 | -0.18 |
| Average Basic Shares Outstanding | 28.53M | 28.53M | 27.79M | 27.79M | 27.17M |
| Average Diluted Shares Outstanding | 28.53M | 28.53M | 27.79M | 27.79M | 27.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |